Panelists discuss how patient-specific factors like age, comorbidities, cytogenetic risk status, and personal preferences guide decisions to deviate from standard protocols, with particular attention ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Identify DCT growth opportunities through market segmentation, competitive rankings, technology trends, strategic alliances, M&A, venture funding and ESG insights.Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE ...
Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering. This ...
Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...
Settling for “good enough” undermines clinical trial quality in drug development and risks trial failure and regulatory rejection. Here’s what pursuing greatness actually requires.
Thought LeadersLiam O'Mahony, Barry Skillington & John MacSharryProf. of Immunology, Cheif Commerical Officer & Research PartnerAtlantia and Clinical Trials Though most people know that their immune ...
A new commentary in the medical journal Pediatrics raises important concerns about the ethics of stopping clinical trials before they are completed, especially when those studies involve children and ...
Amy Nunn and Philip Chan had just started to enroll participants in a federally funded clinical trial for HIV prevention when their work came to an abrupt halt in early March. “I panicked,” said Nunn, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results